The average launch prices for new brand-name drugs and new generic drugs have skyrocketed since 2006, according to an analysis from 46brooklyn, a drug research firm. Using data from Elsevier's Gold Standard Drug Database and the federal government, the analysis found that the median monthly price of a new brand-name drug increased 381% (from $150 to $722) from 2006-2019 while the median monthly price of a new generic drug increased 712% (from about $100 to almost $800) during that period. The report also found that nearly 80% of all generic drugs studied had no decrease in their average wholesale price in the past five years.

Related News Articles

Headline
The Campaign for Sustainable Rx Pricing, for which AHA is a founding member, today launched a petition and digital ad urging drug companies to suspend their “…
Headline
List prices for branded pharmaceutical products in the United States increased 159% between 2007 and 2018, an average of 9.1% per year, according to a study…
Headline
Four drugs used in hospitals for years increased their prices between 525% and 1,644% after receiving formal approval through the Food and Drug Administration’…
Headline
The Food and Drug Administration today approved the first generic albuterol sulfate inhaler to treat and prevent bronchospasms in patients with asthma or…
Headline
The Food and Drug Administration today released the first phase of its searchable Purple Book database, which includes all FDA-approved biosimilar and…
Headline
The House Ways and Means Health Subcommittee yesterday held a hearing on proposals to lower drug prices and promote new cures.  Witness Ge Bai, an…